{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T18:11:43Z","timestamp":1789668703520,"version":"4.0.1"},"reference-count":53,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T00:00:00Z","timestamp":1774310400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000940","name":"Arthritis Australia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000940","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Arthritis and Rheumatism"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.semarthrit.2026.152970","type":"journal-article","created":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T09:22:05Z","timestamp":1773825725000},"page":"152970","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Emergency department presentations and hospital admissions for patients with biopsy-positive giant cell arteritis in South Australia"],"prefix":"10.1016","volume":"78","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9601-142X","authenticated-orcid":false,"given":"Suellen Anne","family":"Lyne","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"Lester","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Stanhope","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanna","family":"Tieu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathryn Ann","family":"Dyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E. Michael","family":"Shanahan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlee Deanne","family":"Ruediger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine Louise","family":"Hill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.semarthrit.2026.152970_bib0001","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1002\/art.24459","article-title":"Epidemiology of giant cell arteritis and polymyalgia rheumatica","volume":"61","author":"Gonzalez-Gay","year":"2009","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2026.152970_bib0002","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2017-000531","article-title":"Geo-epidemiology of temporal artery biopsy-positive giant cell arteritis in australia and new zealand: is there a seasonal influence?","volume":"3","author":"De Smit","year":"2017","journal-title":"RMD Open"},{"key":"10.1016\/j.semarthrit.2026.152970_bib0003","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1186\/s13075-021-02450-w","article-title":"A meta-analysis of the epidemiology of giant cell arteritis across time and space","volume":"23","author":"Li","year":"2021","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.semarthrit.2026.152970_bib0004","article-title":"Incidence of biopsy-proven giant cell arteritis (gca) in south australia 2014-2020","volume":"10","author":"Ninan","year":"2023","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.semarthrit.2026.152970_bib0005","doi-asserted-by":"crossref","first-page":"119","DOI":"10.3899\/jrheum.140318","article-title":"Projected worldwide disease burden from giant cell arteritis by 2050","volume":"42","author":"De Smit","year":"2015","journal-title":"J Rheumatol"},{"key":"10.1016\/j.semarthrit.2026.152970_bib0006","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.berh.2016.05.001","article-title":"Giant cell arteritis","volume":"30","author":"Ninan","year":"2016","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"10.1016\/j.semarthrit.2026.152970_bib0007","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1136\/annrheumdis-2012-202408","article-title":"Large-vessel involvement in giant cell arteritis: a population-based cohort study of the incidence-trends and prognosis","volume":"72","author":"Kermani","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semarthrit.2026.152970_bib0008","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1093\/rheumatology\/keu303","article-title":"Mortality in patients with giant cell arteritis","volume":"54","author":"Baslund","year":"2015","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.semarthrit.2026.152970_bib0009","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.semarthrit.2016.08.015","article-title":"Risk of mortality in patients with giant cell arteritis: a systematic review and meta-analysis","volume":"46","author":"Hill","year":"2017","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2026.152970_bib0010","doi-asserted-by":"crossref","first-page":"73","DOI":"10.7326\/M12-3046","article-title":"Risk for cardiovascular disease early and late after a diagnosis of giant-cell arteritis: a cohort study","volume":"160","author":"Tomasson","year":"2014","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.semarthrit.2026.152970_bib0011","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1080\/21678707.2021.1932458","article-title":"Current and innovative therapeutic strategies for the treatment of giant cell arteritis","volume":"9","author":"Sebastian","year":"2021","journal-title":"Expert Opin Orphan Drugs"},{"key":"10.1016\/j.semarthrit.2026.152970_bib0012","first-page":"14","article-title":"Looking ahead: giant-cell arteritis in 10 years time","author":"Bond","year":"2022"},{"key":"10.1016\/j.semarthrit.2026.152970_bib0013","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1002\/art.11388","article-title":"Glucocorticoid therapy in giant cell arteritis: duration and adverse outcomes","volume":"49","author":"Proven","year":"2003","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2026.152970_bib0014","doi-asserted-by":"crossref","first-page":"189","DOI":"10.2147\/OARRR.S213964","article-title":"A qualitative study of patient perspectives related to glucocorticoid therapy in polymyalgia rheumatica and giant cell arteritis","volume":"11","author":"Hoon","year":"2019","journal-title":"Open Access Rheumatol"},{"issue":"4","key":"10.1016\/j.semarthrit.2026.152970_bib0015","doi-asserted-by":"crossref","DOI":"10.3390\/jcm11041034","article-title":"Impact of glucocorticoid cumulative doses in a real-life cohort of patients affected by giant cell arteritis","volume":"11","author":"Castan","year":"2022","journal-title":"J Clin Med"},{"key":"10.1016\/j.semarthrit.2026.152970_bib0016","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1002\/acr.25081","article-title":"Burden, causes, and outcomes of hospitalization in patients with giant cell arteritis: a us national cohort study","volume":"75","author":"Goulabchand","year":"2023","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"10.1016\/j.semarthrit.2026.152970_bib0017","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/j.semarthrit.2016.10.001","article-title":"Incidence of outcomes potentially associated with corticosteroid therapy in patients with giant cell arteritis","volume":"46","author":"Wilson","year":"2017","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2026.152970_bib0018","doi-asserted-by":"crossref","first-page":"2162","DOI":"10.3899\/jrheum.151500","article-title":"Predictors of cardiovascular hospitalization in giant cell arteritis: effect of statin exposure. A french population-based study","volume":"43","author":"Pugnet","year":"2016","journal-title":"J Rheumatol"},{"key":"10.1016\/j.semarthrit.2026.152970_bib0019","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.semarthrit.2015.02.010","article-title":"Hospitalization rates and utilization among patients with giant cell arteritis: a population-based study from 1987 to 2012","volume":"45","author":"Michet","year":"2015","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2026.152970_bib0020","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.3899\/jrheum.101254","article-title":"Mortality in patients with biopsy-proven giant cell arteritis: a south australian population-based study","volume":"38","author":"Ninan","year":"2011","journal-title":"J Rheumatol"},{"key":"10.1016\/j.semarthrit.2026.152970_bib0021","unstructured":"Australian Bureau of Statistics. Australian Statistical Geography Standard (ASGS) Edition 3 [Internet]. Canberra: ABS; Jul2021-Jun2026 [cited 2025 March 07]. Available from: https:\/\/www.abs.gov.au\/statistics\/standards\/australian-statistical-geography-standard-asgs-edition-3\/latest-release."},{"key":"10.1016\/j.semarthrit.2026.152970_bib0022","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1097\/00005650-199801000-00004","article-title":"Comorbidity measures for use with administrative data","volume":"36","author":"Elixhauser","year":"1998","journal-title":"Med Care"},{"issue":"3","key":"10.1016\/j.semarthrit.2026.152970_bib0023","doi-asserted-by":"crossref","DOI":"10.17061\/phrp2531532","article-title":"Categorising major cardiovascular disease hospitalisations from routinely collected data","volume":"25","author":"Joshy","year":"2015","journal-title":"Public Health Res Pract"},{"key":"10.1016\/j.semarthrit.2026.152970_bib0024","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0135834","article-title":"Validity of diagnostic codes for acute stroke in administrative databases: a systematic review","volume":"10","author":"McCormick","year":"2015","journal-title":"Plos One"},{"key":"10.1016\/j.semarthrit.2026.152970_bib0025","article-title":"Reclassification of icd-9 codes into meaningful categories for oncology survivorship research","volume":"2010","author":"Rassekh","year":"2010","journal-title":"J Cancer Epidemiol"},{"key":"10.1016\/j.semarthrit.2026.152970_bib0026","unstructured":"Independent Hospital Pricing Authority. ICD-10-AM\/ACHI\/ACS Chronicle \u2013 First Edition to Eleventh Edition [Internet]. Sydney: IHPA; 2019 [2025 March 07]. Available from: https:\/\/www.ihpa.gov.au\/what-we-do\/icd-10-am-achi-acs-current-edition."},{"key":"10.1016\/j.semarthrit.2026.152970_bib0027","unstructured":"Lambert P. Stpm3: Stata module to fit flexible parametric survival models [Internet]. Boston College Department of EconomicsA1; 2023. [cited 2025 August 30]. Available from: https:\/\/ideas.repec.org\/c\/boc\/bocode\/s459207.html."},{"key":"10.1016\/j.semarthrit.2026.152970_bib0028","unstructured":"Lambert P. Standsurv: Stata module to compute standardized (marginal) survival and related functions. [Internet]. Boston College Department of EconomicsA1; 2021. [cited 2025 August 30]. Available from: https:\/\/ideas.repec.org\/c\/boc\/bocode\/s458991.html."},{"key":"10.1016\/j.semarthrit.2026.152970_bib0029","unstructured":"Stagg V. Elixhauser: Stata module to calculate elixhauser index of comorbidity. [Internet]Boston College Department of EconomicsA1; 2015. [cited 2025 August 24]. Available from: https:\/\/ideas.repec.org\/c\/boc\/bocode\/s458077.html."},{"key":"10.1016\/j.semarthrit.2026.152970_bib0030","series-title":"The pharmaceutical benefits scheme tocilizumab [internet]","year":"2025"},{"key":"10.1016\/j.semarthrit.2026.152970_bib0031","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1093\/rheumatology\/keu483","article-title":"Inpatient complications in patients with giant cell arteritis: decreased mortality and increased risk of thromboembolism, delirium and adrenal insufficiency","volume":"54","author":"Unizony","year":"2015","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.semarthrit.2026.152970_bib0032","article-title":"Longitudinal trends of hospitalizations for giant cell arteritis: a 21-year longitudinal national population-based study","volume":"15","author":"Hino","year":"2023","journal-title":"Cureus"},{"key":"10.1016\/j.semarthrit.2026.152970_bib0033","doi-asserted-by":"crossref","first-page":"502","DOI":"10.7326\/0003-4819-122-7-199504010-00004","article-title":"Increased incidence of aortic aneurysm and dissection in giant cell (temporal) arteritis: a population-based study","volume":"122","author":"Evans","year":"1995","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.semarthrit.2026.152970_bib0034","doi-asserted-by":"crossref","first-page":"3532","DOI":"10.1002\/art.11480","article-title":"Mortality of large-artery complication (aortic aneurysm, aortic dissection, and\/or large-artery stenosis) in patients with giant cell arteritis: a population-based study over 50 years","volume":"48","author":"Nuenninghoff","year":"2003","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2026.152970_bib0035","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1097\/01.md.0000145366.40805.f8","article-title":"Aortic aneurysm and dissection in patients with biopsy-proven giant cell arteritis from northwestern spain: a population-based study","volume":"83","author":"Gonzalez-Gay","year":"2004","journal-title":"Medicine"},{"issue":"4","key":"10.1016\/j.semarthrit.2026.152970_bib0036","doi-asserted-by":"crossref","DOI":"10.3390\/jcm11041005","article-title":"An updated review of cardiovascular events in giant cell arteritis","volume":"11","author":"de Boysson","year":"2022","journal-title":"J Clin Med"},{"key":"10.1016\/j.semarthrit.2026.152970_bib0037","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1136\/annrheumdis-2019-215672","article-title":"2018 update of the eular recommendations for the management of large vessel vasculitis","volume":"79","author":"Hellmich","year":"2020","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semarthrit.2026.152970_bib0038","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1002\/art.41774","article-title":"2021 american college of rheumatology\/vasculitis foundation guideline for the management of giant cell arteritis and takayasu arteritis","volume":"73","author":"Maz","year":"2021","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.semarthrit.2026.152970_bib0039","doi-asserted-by":"crossref","first-page":"ii11","DOI":"10.1093\/rheumatology\/kex459","article-title":"Prevention of glucocorticoid morbidity in giant cell arteritis","volume":"57","author":"Buttgereit","year":"2018","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.semarthrit.2026.152970_bib0040","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1136\/annrheumdis-2016-209775","article-title":"Eular recommendations for cardiovascular disease risk management in patients with rheumatoid arthritis and other forms of inflammatory joint disorders: 2015\/2016 update","volume":"76","author":"Agca","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semarthrit.2026.152970_bib0041","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1002\/art.39596","article-title":"Incidence of severe infections and infection-related mortality during the course of giant cell arteritis: a multicenter, prospective, double-cohort study","volume":"68","author":"Schmidt","year":"2016","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.semarthrit.2026.152970_bib0042","doi-asserted-by":"crossref","first-page":"2447","DOI":"10.3899\/jrheum.140124","article-title":"Hospitalized infections in giant cell arteritis: a population-based retrospective cohort study","volume":"41","author":"Udayakumar","year":"2014","journal-title":"J Rheumatol"},{"key":"10.1016\/j.semarthrit.2026.152970_bib0043","doi-asserted-by":"crossref","first-page":"2088","DOI":"10.1002\/art.42646","article-title":"2022 american college of rheumatology guideline for the prevention and treatment of glucocorticoid-induced osteoporosis","volume":"75","author":"Humphrey","year":"2023","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.semarthrit.2026.152970_bib0044","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.ijsu.2016.01.005","article-title":"Predictors of acute diverticulitis severity: a systematic review","volume":"26","author":"Tan","year":"2016","journal-title":"Int J Surg"},{"key":"10.1016\/j.semarthrit.2026.152970_bib0045","first-page":"11","article-title":"Steroid-induced sigmoid diverticular perforation in a patient with temporal arteritis: a rare clinical pathology","volume":"5","author":"Kaya","year":"2012","journal-title":"Clin Med Insights: Pathol"},{"key":"10.1016\/j.semarthrit.2026.152970_bib0046","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1007\/s00384-008-0555-4","article-title":"Perforated colonic diverticular disease: the importance of nsaids, opioids, corticosteroids, and calcium channel blockers","volume":"23","author":"Piekarek","year":"2008","journal-title":"Int J Colorectal Dis"},{"key":"10.1016\/j.semarthrit.2026.152970_bib0048","doi-asserted-by":"crossref","first-page":"526","DOI":"10.3899\/jrheum.220610","article-title":"Lower frequency of comorbidities prior to onset of giant cell arteritis: a population-based study","volume":"50","author":"Elfishawi","year":"2023","journal-title":"J Rheumatol"},{"key":"10.1016\/j.semarthrit.2026.152970_bib0049","doi-asserted-by":"crossref","first-page":"3229","DOI":"10.1093\/rheumatology\/keaa080","article-title":"Negative associations for fasting blood glucose, cholesterol and triglyceride levels with the development of giant cell arteritis","volume":"59","author":"Wadstr\u00f6m","year":"2020","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.semarthrit.2026.152970_bib0050","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.semarthrit.2018.07.001","article-title":"Smoking as a risk factor for giant cell arteritis: a systematic review and meta-analysis","volume":"48","author":"Brennan","year":"2018","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2026.152970_bib0051","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1136\/ard.2005.039404","article-title":"Early menopause, low body mass index, and smoking are independent risk factors for developing giant cell arteritis","volume":"65","author":"Larsson","year":"2006","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semarthrit.2026.152970_bib0052","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1093\/rheumatology\/kez289","article-title":"Cardiovascular risk factors associated with polymyalgia rheumatica and giant cell arteritis in a prospective cohort: epic-norfolk study","volume":"59","author":"Yates","year":"2020","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.semarthrit.2026.152970_bib0053","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1002\/msc.1730","article-title":"Health professionals' perspectives on psychological distress and meeting patients' support needs in rheumatology care settings: a qualitative study","volume":"21","author":"Silverthorne","year":"2023","journal-title":"Musculoskeletal Care"},{"key":"10.1016\/j.semarthrit.2026.152970_bib0054","doi-asserted-by":"crossref","first-page":"rkaa016","DOI":"10.1093\/rap\/rkaa016","article-title":"Psychological and self-management support for people with vasculitis or connective tissue diseases: uk health professionals' perspectives","volume":"4","author":"Robson","year":"2020","journal-title":"Rheumatol Adv Pract"}],"container-title":["Seminars in Arthritis and Rheumatism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049017226000594?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049017226000594?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T17:57:08Z","timestamp":1789667828000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049017226000594"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":53,"alternative-id":["S0049017226000594"],"URL":"https:\/\/doi.org\/10.1016\/j.semarthrit.2026.152970","relation":{},"ISSN":["0049-0172"],"issn-type":[{"value":"0049-0172","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Emergency department presentations and hospital admissions for patients with biopsy-positive giant cell arteritis in South Australia","name":"articletitle","label":"Article Title"},{"value":"Seminars in Arthritis and Rheumatism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.semarthrit.2026.152970","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"152970"}}